Delivery Order SPE2DB22D3501-SPE2DB24FWD38

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,536.04 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,146.75 firm fixed-price delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,108.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.99 firm fixed-price delivery order is for the supply of Kerendia 10 mg tablets. The contract has an ultimate completion date of October 18, 2024 and was awarded on October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,272.53 firm fixed-price delivery order contract is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,160.33 delivery order contract is for the supply of KERENDIA 20 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed price arrangement with a completion date of June 4, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,438.02 firm fixed-price delivery order contract is for the supply of KERENDIA 20 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,651.06 firm fixed-price delivery order is for KERENDIA 20 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of July 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $3,406.86 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of the pharmaceutical product KERENDIA 20 MG TABLET 30S, with a period of performance through November 27, 2024. The award was made on November 26, 2024, and there was no set-aside designation for this contract. Amerisourcebergen is a major pharmaceutical...
This federal contract award is a Delivery Order valued at $23,746.09, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a completion date of May 27, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWD38
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,108.44, is a Delivery Order awarded by the Defense Logistics Agency (DLA) for the supply of KERENDIA 10 MG TABLET 30S. The contract has a period of performance through July 2, 2024 and does not have a set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/30/24, 11:14 AM